Alaunos Therapeutics, Inc. (TCRT)
NASDAQ: TCRT · Real-Time Price · USD
2.040
+0.010 (0.49%)
Nov 5, 2024, 4:00 PM EST - Market closed
Alaunos Therapeutics Employees
Alaunos Therapeutics had 1 employees as of December 31, 2023. The number of employees decreased by 33 or -97.06% compared to the previous year.
Employees
1
Change (1Y)
-33
Growth (1Y)
-97.06%
Revenue / Employee
$7,000
Profits / Employee
-$19,129,000
Market Cap
3.27M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Nuwellis | 59 |
Petros Pharmaceuticals | 21 |
Biodexa Pharmaceuticals | 21 |
Palisade Bio | 9 |
Virpax Pharmaceuticals | 7 |
TNF Pharmaceuticals | 6 |
180 Life Sciences | 4 |
Tharimmune | 3 |
TCRT News
- 1 year ago - Alaunos Therapeutics Announces Third Quarter 2023 Financial Results, Phase 1 Clinical Data and Continued Exploration of Strategic Alternatives - GlobeNewsWire
- 1 year ago - Top 5 Health Care Stocks That Could Blast Off This Month - Allakos (NASDAQ:ALLK), BioLife Solns (NASDAQ:BLFS) - Benzinga
- 1 year ago - Alaunos Therapeutics Announces Second Quarter 2023 Financial Results, Interim Clinical Data and Exploration of Strategic Alternatives - GlobeNewsWire
- 1 year ago - Alaunos Therapeutics Announces Presentation at the 2nd Hawaii Global Summit on Thoracic Malignancies - GlobeNewsWire
- 1 year ago - Alaunos Therapeutics to Present Early Data from TCR-T Library Phase 1/2 Trial at 2023 American Society of Clinical Oncology Annual Meeting - GlobeNewsWire
- 1 year ago - Alaunos Therapeutics, Inc. (TCRT) Q1 2023 Earnings Call Transcript - Seeking Alpha
- 1 year ago - Alaunos Therapeutics Reports First Quarter 2023 Financial Results - GlobeNewsWire
- 1 year ago - Alaunos Therapeutics to Report First Quarter 2023 Financial Results on May 10, 2023 - GlobeNewsWire